Glass House Brands Inc. (GLAS) vs Siga Technologies Inc. (SIGA)

Glass House Brands Inc. and Siga Technologies Inc. are both Drug Manufacturers Specialty & Generic companies. Siga Technologies Inc. is the larger, with a market value of $213.4M against $172.7M — 1.2× the size. Glass House Brands Inc. grew revenue faster over the last twelve months: −15.4% against −70.1%. Siga Technologies Inc. has the higher net margin (−5.19% vs −36.2%) and the higher return on invested capital (−14.6% vs −23.4%). Across the 17 metrics below, Siga Technologies Inc. leads on 12 and Glass House Brands Inc. on 5.

Valuation

Metric GLAS SIGA Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 1.14 3.97 2.08
P/B 2.79 1.29 1.79
Price to free cash flow n/m n/m 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.35 4.74 2.87
Earnings yield (33.33%) (1.35%) (15.94%)
Free cash flow yield (18.18%) (9.63%) 0.00%

Profitability

Metric GLAS SIGA Drug Manufacturers Specialty & Generic median
Gross margin 31.97% 54.35% 53.51%
Operating margin (23.18%) (20.76%) 0.00%
Net margin (36.19%) (5.19%) (2.45%)
Free cash flow margin (20.78%) (37.58%) 0.00%
Return on equity (74.02%) (1.49%) (0.80%)
Return on assets (19.78%) (1.36%) (1.67%)
Return on invested capital (23.36%) (14.59%) 0.00%

Growth

Metric GLAS SIGA Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) (15.38%) (70.13%) 5.22%
EPS growth (last fiscal year) (161.90%) (60.98%) 42.91%
Revenue growth, 5-year CAGR — (5.42%) 7.24%
Net income growth, 5-year CAGR — (16.20%) 0.00%

Health

Metric GLAS SIGA Drug Manufacturers Specialty & Generic median
Debt to equity 0.77 0.00 0.04
Current ratio 1.33 21.72 2.41
Net debt to EBITDA (64.84) (6.39) 1.01

Dividend

Metric GLAS SIGA Drug Manufacturers Specialty & Generic median
Dividend yield — 0.00% 1.45%
Payout ratio — — 0.27

Size

Metric GLAS SIGA Drug Manufacturers Specialty & Generic median
Market cap 172.67m 213.40m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack